Continuing in the tradition of 40+ years of tutorials, the 2025 course is designed to update physicians on the latest advances in neoplastic hematopathology. It will be conducted under the direction of Dr. Daniel A. Arber at the Renaissance Phoenix Downtown Hotel from January 20–24, 2025. The program will consist of lectures, case presentations, and discussions designed to provide pathologists, pathologists-in-training, and medical oncologists/ hematologists with an in-depth discussion of diagnostic problems that arise in neoplastic hematopathology.

Target Audience

This activity is designed for pathologists and other healthcare professionals dedicated to the diagnosis of hematological malignancies.

Learning Objectives

At the conclusion of this activity, participants will be able to:

Identify how to evaluate and respond to diagnostic problems that arise in neoplastic hematopathology;

State how to utilize recent advances in the classification of hematopoietic tumors;

Discuss how to interpret and apply immunologic and molecular genetic findings in the diagnosis of neoplastic hematologic disease;

Describe how to implement the most recent classification of hematologic neoplasms;

Recall new discoveries that might impact future classifications of hematologic neoplasms;

Understand the prognostic and therapeutic significance of new molecular genetic markers of these tumors.

Additional information

ACGME/ABMS Core Competencies:

Medical Knowledge

Practice-based Learning and Improvement

Program

Monday, January 20

8:00 AM Introductory Remarks Daniel Arber, MD

Morning Session

Chairperson: Daniel Arber, MD

8:15 AM Normal Lymph Nodes and Reactive Hyperplasias Rebecca King, MD

9:30 AM Introduction to the Classification of Lymphoma James Cook, MD

10:15 AM BREAK

10:30 AM Monoclonal B Lymphocytosis, Chronic Lymphocytic Leukemia and Related B-Cell Leukemias Kathy Foucar, MD

11:45 AM Questions

12:00 PM LUNCH

Afternoon Session

Chairperson: Kathy Foucar, MD

1:30 PM Chronic T/NK Cell Leukemias Kathy Foucar, MD

2:00 PM Lymphoplasmacytic Lymphoma and Nodal and Extranodal Marginal Zone Lymphoma James Cook, MD, PhD

3:00 PM Questions

3:15 PM BREAK

3:30 PM Mantle Cell Lymphoma, Follicular Lymphoma and Variants Rebecca King, MD

4:30 PM Questions

4:45 PM-

5:30 PM

Case Presentations Rebecca King, MD, James Cook, MD, PhD &

Kathy Foucar, MD

Tuesday, January 21

Morning Session

Chairperson: Michael Borowitz, MD

8:00 AM Peripheral T Cell Lymphoma and Anaplastic Large Cell Lymphoma Elaine Jaffe, MD

9:30 AM Questions

9:45 AM BREAK

10:00 AM Acute Lymphoblastic Leukemia/Lymphoma and Acute Leukemias of Ambiguous Lineage Michael Borowitz, MD

11:30 AM Questions

11:45 AM Case Presentations Michael Borowitz, MD &

Elaine Jaffe, MD

12:15 PM LUNCH

Afternoon Session

Chairperson: Rebecca King, MD

1:45 PM Diffuse, Aggressive B Cell Lymphomas Rebecca King, MD

2:45 PM Questions

3:00 PM BREAK

3:15 PM Lymphoma Diagnosis: A Clinician’s Perspective Javier Munoz, MD, MBA

4:15 PM Questions

4:30 PM-

5:00 PM

Case Presentations Rebecca King, MD

Wednesday, January 22

Morning Session

Chairperson: Jonathan Said, MD

8:00 AM Splenic Tumors Daniel Arber, MD

9:00 AM Hodgkin Lymphoma Amy Chadburn, MD

10:00 AM Questions

10:15 AM BREAK

10:30 AM Immunodeficiency-and Viral-Associated Lymphoproliferations Jonathan Said, MD

11:45 AM Questions

12:00 PM LUNCH

Afternoon Session

Chairperson: Amy Chadburn, MD

1:30 PM Histiocytic Disorders Amy Chadburn, MD

2:45 PM Questions

3:00 PM BREAK

3:15 PM Cutaneous Lymphomas Jonathan Said, MD

4:15 PM Questions

4:30 PM-

5:00 PM

Case Presentations Daniel Arber, MD

Jonathan Said, MD &

Amy Chadburn, MD

Thursday, January 23

Morning Session

Chairperson: Adam Bagg, MD

8:00 AM Introduction to the Classification of Myeloid Neoplasms and Acute Leukemia Daniel Arber, MD

8:45 AM Chronic Myeloid Leukemia Adam Bagg, MD

9:30 AM Questions

9:45 AM BREAK

10:00 AM BCR: ABL1--negative Myeloproliferative Neoplasms Attilio Orazi, MD

11:00 AM Eosinophilic Disorders Adam Bagg, MD

11:45 AM Questions

12:00 PM LUNCH

Afternoon Session

Chairperson: Robert Lorsbach, MD

1:30 PM Clonal Cytopenias and Myelodysplastic Syndrome Robert Hasserjian, MD

2:45 PM Pediatric and Germline Predisposition Syndromes Robert Lorsbach, MD

3:30 PM Questions

3:45 PM BREAK

4:00 PM Plasma Cell Neoplasms Robert Lorsbach, MD, PhD

4:45 PM Questions

5:00 PM-

5:45 PM

Case Presentations Robert Hasserjian, MD & Robert Lorsbach, MD, PhD

Friday, January 24

Morning Session

Chairperson: Daniel Arber, MD

8:00 AM Myelodysplastic/Myeloproliferative Neoplasms Attilio Orazi, MD

9:00 AM Acute Myeloid Leukemias Daniel Arber, MD

10:00 AM Questions

10:15 AM BREAK

10:30 AM Mastocytosis Attilio Orazi, MD

11:15 AM Case Presentations Daniel Arber, MD & Attilio Orazi, MD

11:45 AM Questions

12:00 PM-

12:30 PM

Concluding Remarks